Stocks in news: ICICI Lombard, ICICI Pru Life, IREDA, Dr Reddy's, GAIL

Domestic markets wrapped up the last week on a strong note, gaining nearly 2%, buoyed by positive global cues. In today's trade, shares of ICICI Lombard, ICICI Pru Life, IREDA, Dr Reddy's, GAIL among others will be in focus due to various news developments and fourth quarter results.

ICICI Lombard, ICICI Pru Life, IREDA
Shares of ICICI Lombard, ICICI Pru Life and IREDA will be in focus in today's trade as the companies will announce their quarterly results.

Dr Reddy's
Dr Reddy's has denied the workforce reduction claims. "We categorically deny the claim of a 25% workforce cost reduction and the other claims mentioned in the said news article," the company said.

GAIL India
GAIL India issued a tender on Friday to buy an up to 26% stake in a liquefied natural gas project in the United States combined with a 15-year gas import deal, aiding New Delhi's efforts to narrow its trade surplus with Washington.

Aurobindo Pharma
Aurobindo Pharma has received final approval from the United States Food and Drug Administration (USFDA) to make and sell Rivaroxaban Tablets USP, 2.5mg — the generic equivalent of Janssen Pharmaceuticals’s blockbuster drug, Xarelto 2.5mg.

NHPC
NHPC has commenced commercial operations of 107.14 megawatts (MW) at its 300 MW solar photovoltaic (PV) project in Karnisar, Bikaner, Rajasthan.

Ashoka Buildcon
Ashoka Buildcon declared as the L-1 bidder for a project worth Rs 569 crore by Central Railway.

Repco Home Finance
Repco Home Finance appointed Thangappan Karunakaran as Managing Director and Chief Executive Officer (MD & CEO) of the company with effect from April 11.

Union Bank
The government re-nominated Suraj Srivastava as the part-time non-official director (independent director) on the bank’s board with effect from April 11.

JK Cement
The board of JK Cement will consider fund raising of up to Rs 500 crore through NCDs on May 24.